Who Paid My Doc
Barry Gertz
Endocrinology, Diabetes & Metabolism Rahway, NJ Medical Doctor
NPI 1891954848 CMS profile 759295
126 E Lincoln Ave, Rahway, NJ 07065
General payments
$903,187
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Barry Gertz of Rahway, NJ is reported in the CMS Open Payments database as having received $903,187 across 85 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $119,157 | 8 | |
| 2024 | General | $89,748 | 9 | |
| 2023 | General | $170,938 | 10 | |
| 2022 | General | $99,376 | 7 | |
| 2021 | General | $147,975 | 16 | |
| 2020 | General | $136,500 | 17 | |
| 2019 | General | $139,493 | 18 |
Beside peers
- Barry Gertz
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Barry Gertz were reported at $119,157. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Barry Gertz | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $139,493 | $494 | $123–$2,253 | $163 |
| 2020 | $136,500 | $335 | $85–$1,841 | $114 |
| 2021 | $147,975 | $398 | $88–$1,981 | $132 |
| 2022 | $99,376 | $364 | $88–$1,568 | $149 |
| 2023 | $170,938 | $420 | $113–$1,614 | $160 |
| 2024 | $89,748 | $440 | $121–$1,646 | $164 |
| 2025 | $119,157 | $507 | $135–$1,838 | $169 |
Breakdown
Records
85 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in New Jersey
Nawras Makhsida
Endocrinology, Diabetes & Metabolism · Randolph, NJ
Marc Sandberg
Endocrinology, Diabetes & Metabolism · Flemington, NJ
Joanne Waldstreicher
Endocrinology, Diabetes & Metabolism · New Brunswick, NJ
Gregory Barone
Endocrinology, Diabetes & Metabolism · Cherry Hill, NJ
Navtika Desai
Endocrinology, Diabetes & Metabolism · Hillsborough, NJ
Taher Modarressi
Endocrinology, Diabetes & Metabolism · Pennington, NJ
Related records
Endocrinology, Diabetes & Metabolism in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.